|
1
|
Schwab M, Westermann F, Hero B and
Berthold F: Neuroblastoma: Biology and molecular and chromosomal
pathology. Lancet Oncol. 4:472–480. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mora J, Gerald WL, Qin J and Cheung NK:
Evolving significance of prognostic markers associated with
treatment improvement in patients with stage 4 neuroblastoma.
Cancer. 94:2756–2765. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Bernardi B, Mosseri V, Rubie H, et al
SIOP Europe Neuroblastoma Group: Treatment of localised resectable
neuroblastoma. Results of the LNESG1 study by the SIOP Europe
Neuroblastoma Group. Br J Cancer. 99:1027–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Look AT, Hayes FA, Nitschke R, et al:
Cellular DNA content as a predictor of response to chemotherapy in
infants with unresectable neuroblastoma. N Engl J Med. 311:231–235.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Matthay KK, Reynolds CP, Seeger RC, et al:
Long-term results for children with high-risk neuroblastoma treated
on a randomized trial of myeloablative therapy followed by
13-cis-retinoic acid: A children's oncology group study. J Clin
Oncol. 27:1007–1013. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Burgues O, Navarro S, Noguera R, Pellín A,
Ruiz A, Castel V and Llombart-Bosch A: Prognostic value of the
International Neuroblastoma Pathology Classification in
Neuroblastoma (Schwannian stroma-poor) and comparison with other
prognostic factors: A study of 182 cases from the Spanish
Neuroblastoma Registry. Virchows Arch. 449:410–420. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Parise IZ, Haddad BR, Cavalli LR, et al:
Neuroblastoma in southern Brazil: An 11-year study. J Pediatr
Hematol Oncol. 28:82–87. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hesseling PB, Ankone K, Wessels G,
Schneider JW, Du Plessis L and Moore S: Neuroblastoma in southern
Africa: Epidemiological features, prognostic factors and outcome.
Ann Trop Paediatr. 19:357–363. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goodman MT, Gurney JG, Smith MA, et al:
Sympathetic nervous system tumors. In: Cancer incidence and
survival among children and adolescents: United States SEER Program
1975–1995National Cancer Institute. SEER Program. NIH Pub.
No.99-4649. Ries LAG, Smith MA, Gurney JG, et al: Bethesda, MD:
1999
|
|
10
|
Carlsen NLT, Christensen IJ, Schroeder H,
Bro PV, Erichsen G, Hamborg-Pedersen B, Jensen KB and Nielsen OH:
Prognostic factors in neuroblastomas treated in Denmark from 1943
to 1980. A statistical estimate of prognosis based on 253 cases.
Cancer. 58:2726–2735. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schroeder H, Wacher J, Larsson H, Rosthoej
S, Rechnitzer C, Petersen BL and Carlsen NL: Unchanged incidence
and increased survival in children with neuroblastoma in Denmark
1981–2000: A population-based study. Br J Cancer. 100:853–857.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
al-Mulhim I: Neuroblastoma in children: A
10-year experience in Saudi Arabia. J Trop Pediatr. 44:77–80. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aydn GB, Kutluk MT, Yalçn B, Büyükpamukçu
M, Kale G, Varan A, Akyüz C, Senocak ME and Büyükpamukçu N:
Neuroblastoma in Turkish children: Experience of a single center. J
Pediatr Hematol Oncol. 31:471–480. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wilson LM and Draper GJ: Neuroblastoma,
its natural history and prognosis: A study of 487 cases. BMJ.
3:301–307. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moon SB, Park KW, Jung SE and Youn WJ:
Neuroblastoma: Treatment outcome after incomplete resection of
primary tumors. Pediatr Surg Int. 25:789–793. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Méhes G, Luegmayr A, Kornmüller R, Ambros
IM, Ladenstein R, Gadner H and Ambros PF: Detection of disseminated
tumor cells in neuroblastoma: 3 log improvement in sensitivity by
automatic immunofluorescence plus FISH (AIPF) analysis compared
with classical bone marrow cytology. Am J Pathol. 163:393–399.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Juárez-Ocaña S, Palma-Padilla V,
González-Miranda G, Siordia-Reyes AG, López-Aguilar E,
Aguilar-Martínez M, Mejía-Aranguré JM, Carreón-Cruz R,
Rendón-Macías ME and Fajardo-Gutiérrez A: Epidemiological and some
clinical characteristics of neuroblastoma in Mexican children
(1996–2005). BMC Cancer. 9:2662009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spix C, Aareleid T, Stiller C, Magnani C,
Kaatsch P and Michaelis J: Survival of children with neuroblastoma.
time trends and regional differences in Europe, 1978–1992. Eur J
Cancer. 37:722–729. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Arzanian MT and Esfahani H: Neuroblastoma;
variable symptoms of a neurogenic tumor; a report from Iran. IJCN.
3:33–39. 2008.
|
|
20
|
Grosfeld JL: Risk-based management of
solid tumors in children. Am J Surg. 180:322–327. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Joshi VV, Cantor AB, Altshuler G, et al:
Age-linked prognostic categorization based on a new histologic
grading system of neuroblastomas. A clinicopathologic study of 211
cases from the Pediatric Oncology Group. Cancer. 69:2197–2211.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berthold F, Kassenböhmer R and Zieschang
J: Multivariate evaluation of prognostic factors in localized
neuroblastoma. Am J Pediatr Hematol Oncol. 16:107–115.
1994.PubMed/NCBI
|
|
23
|
Breslow N and McCann B: Statistical
estimation of prognosis for children with neuroblastoma. Cancer
Res. 31:2098–2103. 1971.PubMed/NCBI
|
|
24
|
Saito T, Tsunematsu Y, Saeki M, Honna T,
Masaki E, Kojima Y and Miyauchi J: Trends of survival in
neuroblastoma and independent risk factors for survival at a single
institution. Med Pediatr Oncol. 29:197–205. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Powell JE, Estève J, Mann JR, Parker L,
Frappaz D, Michaelis J, Kerbl R, Mutz ID and Stiller CA:
Neuroblastoma in Europe: Differences in the pattern of disease in
the UK. SENSE. Study group for the Evaluation of Neuroblastoma
Screening in Europe. Lancet. 352:682–687. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schmidt ML, Lukens JN, Seeger RC, et al:
Biologic factors determine prognosis in infants with stage IV c. J
Clin Oncol. 18:1260–1268. 2000.PubMed/NCBI
|
|
27
|
Cotterill SJ, Pearson AD, Pritchard J,
Foot AB, Roald B, Kohler JA and Imeson J: Clinical prognostic
factors in 1277 patients with neuroblastoma: Results of The
European Neuroblastoma Study Group ‘Survey’ 1982–1992. Eur J
Cancer. 36:901–908. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cohn SL, Pearson AD, London WB, et al INRG
Task Force: The International Neuroblastoma Risk Group (INRG)
classification system: An INRG Task Force report. J Clin Oncol.
27:289–297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Matthay KK, Perez C, Seeger RC, et al:
Successful treatment of stage III neuroblastoma based on
prospective biologic staging: A Children's Cancer Group study. J
Clin Oncol. 16:1256–1264. 1998.PubMed/NCBI
|
|
30
|
Bernard JL, Philip T, Zucker JM, et al:
Sequential cisplatin/VM26 and
vincristine/cyclophosphamide/doxorubicin in metastatic
neuroblastoma: An effective alternating non-cross-resistant
regimen? J Clin Oncol. 5:1952–1959. 1987.PubMed/NCBI
|
|
31
|
Bagatell R, Rumcheva P, London WB, et al:
Outcomes of children with intermediate-risk neuroblastoma after
treatment stratified by MYCN status and tumor cell ploidy. J Clin
Oncol. 23:8819–8827. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
London WB, Castleberry RP, Matthay KK, et
al: Evidence for an age cutoff greater than 365 days for
neuroblastoma risk group stratification in the Children's Oncology
Group. J Clin Oncol. 23:6459–6465. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schilling FH, Spix C, Berthold F, et al:
Neuroblastoma screening at one year of age. N Engl J Med.
346:1047–1053. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shimada H, Umehara S, Monobe Y, et al:
International neuroblastoma pathology classification for prognostic
evaluation of patients with peripheral neuroblastic tumors: A
report from the Children's Cancer Group. Cancer. 92:2451–2461.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pritchard J and Hickman JA: Why does stage
4s neuroblastoma regress spontaneously. Lancet. 344:869–870. 1994.
View Article : Google Scholar : PubMed/NCBI
|
